These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 26637714)

  • 1. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.
    Delaney M; Matthews DC
    Hematology Am Soc Hematol Educ Program; 2015; 2015():146-51. PubMed ID: 26637714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on HDFN: new information on long-standing controversies.
    Eder AF
    Immunohematology; 2006; 22(4):188-95. PubMed ID: 17430078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. History and current standard of postnatal management in hemolytic disease of the fetus and newborn.
    De Winter DP; Hulzebos C; Van 't Oever RM; De Haas M; Verweij EJ; Lopriore E
    Eur J Pediatr; 2023 Feb; 182(2):489-500. PubMed ID: 36469119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Haemolytic disease of the fetus and newborn/HDFN/timing in pregnant women and prophylaxis].
    Kulinska R
    Akush Ginekol (Sofiia); 2014; 53(2):58-63. PubMed ID: 25098112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red Blood Cell Alloimmunization in the Pregnant Patient.
    Webb J; Delaney M
    Transfus Med Rev; 2018 Oct; 32(4):213-219. PubMed ID: 30097223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful use of maternal blood in the management of severe hemolytic disease of the fetus and newborn due to anti-Kp(b).
    Bleile MJ; Rijhsinghani A; Dwyre DM; Raife TJ
    Transfus Apher Sci; 2010 Dec; 43(3):281-283. PubMed ID: 20951648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
    Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
    Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
    Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
    Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn.
    Quantock KM; Lopez GH; Hyland CA; Liew YW; Flower RL; Niemann FJ; Joyce A
    Transfusion; 2017 Aug; 57(8):1938-1943. PubMed ID: 28639307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive approach for the management of hemolytic disease of the fetus.
    Illanes S; Soothill P
    Expert Rev Hematol; 2009 Oct; 2(5):577-82. PubMed ID: 21083022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of Villous Immaturity in Term Deliveries Following Intrauterine Transfusion for Parvovirus B19 Infection and RhD-associated Hemolytic Disease of the Fetus and Newborn.
    McCarthy WA; Popek EJ
    Pediatr Dev Pathol; 2017; 20(6):469-474. PubMed ID: 29187036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus.
    Li S; He Z; Mo C; Ji Y; Luo Y; Fang Q; Gao Y
    Transfusion; 2021 Jun; 61(6):1908-1915. PubMed ID: 33938570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of anti-Jka alloimmunization.
    Franco A; Rossi K; Krugh D; O'Shaughnessy R
    J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
    Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature.
    Al Riyami AZ; Al Salmani M; Al Hashami S; Al Mahrooqi S; Al Hinai S; Al Balushi H; Al Riyami N; Gowri V; Al Dughaishi T; Al Hosni S; Al-Khabori M; Al-Farsi K; Al Huneini M; Alkindi S
    Transfusion; 2014 Jan; 54(1):238-43. PubMed ID: 23829228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
    Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.
    Rath ME; Smits-Wintjens VE; Lindenburg IT; Folman CC; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
    Transfusion; 2013 Jul; 53(7):1580-5. PubMed ID: 23113703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolytic disease of the fetus and newborn in the molecular era.
    Fasano RM
    Semin Fetal Neonatal Med; 2016 Feb; 21(1):28-34. PubMed ID: 26589360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.